AURA 2023 includes data and analyses from 2020–2022 (primarily 2020–2021) from various sources and reports on patterns and trends in antimicrobial use and appropriateness and antimicrobial resistance (AMR) in Australian acute and community healthcare settings.
The Antimicrobial Use and Resistance in Australia (AURA) Surveillance System collects, reviews and analyses data on antimicrobial use and antimicrobial resistance in human health.
This complete version of the Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard describes what each quality statement means for patients and their families, clinicians, and health service organisations, and provides indicators for local monitoring. It includes information about using clinical care standards, and the background and evidence sources for this standard.
On the Radar Issue 699 is now available.
This issue includes items on the new Australian Safety and Quality Medical Imaging Accreditation Scheme, digital health literacy, performance, mental health, gaming and e-sports, health technology assessment, older patients, transitions of care, rheumatoid arthritis, and more. Along with the latest from BMJ Quality & Safety, Australian Health Review, Health Affairs, International Journal for Quality in Health Care and the UK’s NICE.
The MedicineInsight Continuing Professional Development Guide: COPD 2025 is a Quality Improvement Guide accompanying the MedicineInsight Practice Report: COPD 2025. Participating practices are offered COPD-focused quality improvement activities to align with best practice and identify key areas for improvement, benefiting patients. This activity can contribute to RACGP CPD mandatory requirements for participating GPs.
On the Radar Issue 698 is now available.
This quarterly update includes data submitted to CARAlert for the reporting period 1 January to 31 March 2025. These data support the prevention and control of critical antimicrobial resistances.
This issue includes items on the Australian Hospital Patient Experience Question Set for parents and carers (AHPEQS-Parent), patient safety, chronic conditions and more. Along with the latest from BMJ Quality & Safety,Residential Aged Care Communiqué, The Joint Commission Journal on Quality and Patient Safety and the UK’s NICE and the USA’s AHRQ.
The Commission is seeking an ongoing, full-time EL2 Director, Medicines Safety and Quality and Infection Prevention and Control.
Information on this vacancy and how to apply can be found in the link below. Applications for this role will close 11.59pm Australian Eastern Standard Time (AEST), Sunday 15 June 2025.
Questions about the role can be directed to Chris Leahy (02) 7232 6040.